Q Fever News and Research

RSS

Microgravity culture during spaceflight enhances microbial infection process in 3D intestinal models

Infectious microbes have evolved sophisticated means to invade host cells, outwit the body's defenses and cause disease.

1 Jun 2022

The impact of SARS-CoV-2 linkage on outcomes in hospitalized children with PIMS across Canada

Researchers analyze the clinical effects and implications of SARS-CoV-2 infection in children who were hospitalized due to MIS-C.

1 Jun 2022

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Researchers assessed the neutralizing activity against SARS-CoV-2 Omicron variant after tixagevimab plus cilgavimab (T+C) administration.

30 May 2022

Study highlights clinical features and treatment approaches for human monkeypox in the UK

researchers from the UK unveil the details of imported, household, and hospital transmission of monkeypox and report the first usage of two specific antiviral agents in the treatment of this disease.

30 May 2022

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Researchers identify symptoms and systematic conditions associated with PASC in children

30 May 2022

Zoonotic and public health implications of bovine and human brucellosis in Ethiopia

Announcing a new article publication for Zoonoses journal. Bovine brucellosis is endemic and widely distributed in Ethiopia.

27 May 2022

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its covid vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

26 May 2022

Study describes the symptom profiles of the main variants of SARS-CoV-2

Researchers assessed the severe SARS-CoV-2 variant-specific COVID-19 symptoms among residents of England.

26 May 2022

Staying physically active before COVID-19 infection can help reduce disease severity

A consortium of Luxembourgish research institutions studying the national population have been looking to identify factors that may contribute to variations in severity of COVID-19 and its associated symptoms.

26 May 2022

We need to prepare for Monkeypox - now confirmed in 21 countries

Efforts should be made to curb the spread of this virus in order to prevent another pandemic.

25 May 2022

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

While the attention of public health authorities has been rivetted on the current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, many other viruses have been stealthily circling the globe, causing serious disease and death in humans and other animals.

25 May 2022

A study on the safety of BNT162b2 COVID vaccine in children under five

In a recent research paper posted to the medRxiv* preprint server, scientists explored the safety of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine in children under five years of age.

25 May 2022

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

A recent study currently under review at Scientific Reports journal and posted to the Research Square* preprint server demonstrated a potential positive correlation between reactogenicity and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination.

25 May 2022

The root causes of long-COVID still a mystery

In a recent article posted to the journal Annals of Internal Medicine, researchers presented baseline outcomes from a longitudinal assessment of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), also known as long-COVID.

25 May 2022

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers evaluated the efficacy of messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 in cancer patients under treatment with immune checkpoint inhibitors (ICIs).

25 May 2022

Q Fever News and Research

Microgravity culture during spaceflight enhances microbial infection process in 3D intestinal models

The impact of SARS-CoV-2 linkage on outcomes in hospitalized children with PIMS across Canada

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Study highlights clinical features and treatment approaches for human monkeypox in the UK

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Zoonotic and public health implications of bovine and human brucellosis in Ethiopia

Novavax missed its global moonshot but is angling to win over mRNA defectors

Study describes the symptom profiles of the main variants of SARS-CoV-2

Staying physically active before COVID-19 infection can help reduce disease severity

We need to prepare for Monkeypox - now confirmed in 21 countries

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

A study on the safety of BNT162b2 COVID vaccine in children under five

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

The root causes of long-COVID still a mystery

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Anosmia in pediatric COVID-19

Study reports on the first instances of in-hospital, household transmission of monkeypox

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

Research provides new insight into how Crimean-Congo hemorrhagic fever virus causes disease

Evaluating the safety of COVID-19 vaccines in younger children

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News